The clinical value of identifying genetic abnormalities that can be targeted in cholangiocarcinomas
Sign Up to like & getrecommendations! Published in 2023 at "Expert Review of Anticancer Therapy"
DOI: 10.1080/14737140.2023.2170878
Abstract: ABSTRACT Introduction Cholangiocarcinomas (CCAs) are a heterogenous group of epithelial malignancies originating at any level of the biliary tree and are subdivided according to their location into intrahepatic (iCCA) and extrahepatic (eCCA). Areas covered This… read more here.
Keywords: abnormalities targeted; clinical value; value identifying; targeted cholangiocarcinomas ... See more keywords